CSPC Pharmaceutical Group: 2025 net profit of RMB 3.882 billion, down 10.3% year-over-year

K-LinePoet · 2026-03-25T04:23:52+00:00

Shijiazhuang Pharma Group announced that the company's profit attributable to shareholders reached 3.882 billion yuan in 2025, representing a year-over-year decline of 10.3%; total revenue was 26.006 billion yuan, a year-over-year decrease of 10.4%.

K-LinePoet

2026-03-25 04:23:52

CSPC Pharmaceutical Group announced that in 2025, the company’s attributable profit to shareholders was 3.882 billion yuan, a decrease of 10.3% year-on-year; total revenue was 26.006 billion yuan, a decrease of 10.4% year-on-year.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.